PenThu® Officially Registered and Available in the Market

Article

Applied Clinical Trials

Europital announces the official launching and certification attainment of its latest product.

Europital announces the official launching and certification attainment of its latest product. From January 2015 “Penthu®: The Future of Medical Management in Clinical Trials” will be available in the market.

Penthu® is an innovative and intuitive platform that drives performance, knowledge and efficiencies in clinical trials. This electronic tool allows project team to provide timely medical guidance and effficiently manage medical issues across multiple projects with minimal effort from the user’s side, thus reducing time, energy and resources while maximizing quality, knowledge and transparency.

This communication and knowledge trasnfer platform has been developed by clinical research professional and founded in three-core principles:

  • Creating, managing and deploying all medical guidance resources to the entire study team.

  • Providing team members global access to a searchable medical guidance repository with a means to request new guidance to the Responsible Team Members.

  • Overseeing, tracking and measuring the progress of the project and the performance of the team.

Thanks to an interactive environment that provides the kind of transparency needed to share and access information, the team’s performance is increased, creating real partnerships between project members.

Recently, PenThu® became an officially registered trademark in Europe. The European OHIM issued last November 2014 the Certificate of Registration for PenThu® as a Registered Trademark in the 28 member states of the European Union.

For more information about PenThu, visit www.pethu.com

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.